Invenra Signs Research Deal with Astellas Pharma to Boost Bispecific Therapeutic Research
Invenra Inc. has forged a strategic research agreement with Astellas Pharma, a global pharmaceutical company with a vision to turn innovative science into value for patients.
Therapeutics | 10/04/2024 | By Aishwarya | 191
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy